Literature DB >> 64129

Urticaria. An updated review.

E W Monroe, H E Jones.   

Abstract

Urticaria can result from many different stimuli, and numerous factors, both immunologic and nonimmunologic, are involved in its pathogenesis. Most commonly considered of immunologic mechanisms is the type I hypersensitivity state mediated by IgE. Another immunologic mechanism involves the activation of the complement cascade, which produces anaphylatoxins that can release histamine. Immunologic, nonimmunologic, genetic, and modulating factors converge on mast cells and basophils to release mediators capable of producing urticarial lesions. In addition to the clinical and laboratory diagnosis and treatment regimens, we review such mediators as histamine, kinins, serotonin, slow-reacting substance of anaphylaxis, prostaglandins, acetylcholine, fibrin degradation products, and anaphylatoxins that increase vascular permeability and can thereby produce wheals. Special consideration is given to histamine and the factors that regulate is secretory release from mast cells and basophils, including the modulating role of intracellular levels of cyclic adenosine monophosphate.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 64129     DOI: 10.1001/archderm.113.1.80

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  8 in total

Review 1.  Urticaria and angioedema.

Authors:  B A Burrall; A C Huntley
Journal:  Clin Rev Allergy       Date:  1985-02

2.  Chronic urticaria.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-26

3.  Physical agents that mediate urticaria.

Authors:  C Easwaran; G Beall
Journal:  West J Med       Date:  1979-10

4.  HLA antigens and urticaria.

Authors:  D van Neste; C Bouillenne
Journal:  Arch Dermatol Res       Date:  1978-04-07       Impact factor: 3.017

Review 5.  Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-07       Impact factor: 9.546

Review 6.  Oxatomide. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-03       Impact factor: 9.546

7.  Enhanced weal and flare response to histamine in chronic idiopathic urticaria.

Authors:  L B Krause; S Shuster
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

8.  Avoidance Behavior against Positive Allergens Detected with a Multiple Allergen Simultaneous Test Immunoblot Assay in Patients with Urticaria: Factors Associated with Avoidance Success/Failure.

Authors:  Min Kyung Lee; In Ho Kwon; Han Su Kim; Heung Yeol Kim; Eun Byul Cho; Youin Bae; Gyeong Hun Park; Eun Joo Park; Kwang Ho Kim; Kwang Joong Kim
Journal:  Ann Dermatol       Date:  2016-01-28       Impact factor: 1.444

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.